Fig. 1. SLC16A3 is an oncogene for human thyroid cancer progression. Unmatched (A) and matched (B) comparison of mRNA expression of SLC16A3 between normal thyroid and ATC tissues in GSE65144. (C, D) Comparison of SLC16A3 mRNA expression between normal thyroid, PTC, and ATC tissues in GSE29265 (C) and GSE33630 (D). Statistical analyses were performed using a two-tailed Student t-test. Data represent the mean±standard deviation. Asterisks (*p<0.05, **p<0.01, ***p<0.001, and ****p<0.0001) indicate significant differences from the statistical analyses. ATC: anaplastic thyroid carcinoma, PTC: papillary thyroid carcinoma

Int J Thyroidol 2024;17:272-6 https://doi.org/10.11106/ijt.2024.17.2.272

© 2024 Int J Thyroidol